DP015 | EPCORITAMAB + R-ICE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION: EPCORE NHL-2

Introduction: Pts with LBCL are often refractory to salvage chemoimmunotherapy (CIT). An unmet need remains to optimize salvage therapy (tx), allowing more pts to go to ASCT. We present results from the NHL-2 trial (NCT04663347) of epcor, a subcutaneous CD3xCD20 bispecific antibody, plus R-ICE in p...

Descripció completa

Dades bibliogràfiques

Autors principals:	G. Musuraca, S. De Vos, D. Morillo, R. Cordoba, P. Gomez Prieto, J. Darrah, E. Hawkes, R. Mous, A. Sureda, R.W. Merryman, T. Jiang, J. Marek, L. Wang, M. Risum, C. Thieblemont, P. Abrisqueta, M. Trneny, U. Vitolo
Format:	Artigo
Idioma:	Inglês
Publicat:	Ferrata Storti Foundation 2025-09-01
Col·lecció:	Haematologica
Accés en línia:	https://haematologica.org/article/view/12779
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!